MedPath

Efficacy of Laughter Yoga and anti-anxiety drugs on irritable bowel syndrome

Phase 2
Recruiting
Conditions
Irritable Bowel Syndrome.
Irritable bowel syndrome without diarrhoea ,Irritable bowel syndrome with diarrhoea
K58.9, K58
Registration Number
IRCT20170829035966N1
Lead Sponsor
Vice Chancellor for research of Birjand University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients aged between 18 and 50 years old
Patients who accepted to participate in the study after explaining the purposes of the study and advantages and disadvantages of the interventions
There should be the possibility to keep the type and dose of the medications fixed during the study
Patients who do not have psychotic or personality disorders
Patients who do not have alarm signs including gastrointestinal bleeding, blood in stool, fever, weight loss, anemia, diarrhea at night, severe abdominal pain and so on

Exclusion Criteria

Patients who receive psychological treatments before entering the study
Patients who have any other anatomical or functional gastrointestinal disorders

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Irritable Bowel Syndrome severity. Timepoint: Before and right after the end of intervention. Method of measurement: Irritable Bowel Syndrome severity score system designed by Francis CY in 1997: mild (8 to 18) - moderate (18 to 30) - severe ( more than 30).
Secondary Outcome Measures
NameTimeMethod
Anxiety severity. Timepoint: Before and right after the end of intervention. Method of measurement: Anxiety score from beck anxiety inventory.
© Copyright 2025. All Rights Reserved by MedPath